Ali AlBahar/ LinkedIn
May 2, 2026, 05:23
Ali AlBahar: Ensuring Safety and Precision Across the Blood Transfusion Process
Ali AlBahar, Transfusion Medicine Specialist, Hematology and Blood Transfusion Researcher (MSc) at Ministry of Health Saudi Arabia, shared a post on LinkedIn:
“Blood transfusion is not a single act — it is a controlled clinical chain.
From donor selection to processing, testing, transfusion and monitoring, every step carries responsibility.
A small deviation at any point can impact patient safety.
This is not just a process… it is a system designed to prevent error before it happens.
In transfusion medicine: precision is not optional — it is essential.
BB.H.05 — The Transfusion Chain.
Blood Bank Educational Series.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines